Evidence of interferon β-1a dose response in relapsing-remitting MS

Rating neurologic impairment in multiple sclerosis

1983 • 14,011 citations

New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

1983 • 7,404 citations

Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

1996 • 2,410 citations

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1998 • 2,049 citations

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

1993 • 2,032 citations

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

1993 • 1,908 citations

Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis

1998 • 931 citations

Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosis

1998 • 334 citations

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis

1998 • 332 citations

Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy

1999 • 279 citations

A neurologic rating scale (NRS) for use in multiple sclerosis

1984 • 245 citations

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis

1997 • 234 citations

Interferon-β inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis

1996 • 153 citations

Systemic Recombinant Human Interferon-β Treatment of Relapsing–Remitting Multiple Sclerosis: Pilot Study Analysis and Six-Year Follow-Up

1993 • 109 citations

Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.

1996 • 105 citations

Comparative Study of the Pharmacodynamic and Pharmacologic Effects of Betaseron^®and AVONEX^™

1998 • 92 citations

Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta‐1a after intramuscular and subcutaneous administration

1998 • 92 citations

Pharmacodynamics of Biological Response In Vivo After Single and Multiple Doses of Interferon?????

1993 • 64 citations

Perils and Pitfalls in the Interpretation of Clinical Trials: A Reflection on the Recent Experience in Multiple Sclerosis

1999 • 58 citations

Pharmacokinetics and Pharmacodynamics of Interferon Beta-1a (IFN??-1a) in Healthy Volunteers after Intravenous, Subcutaneous or Intramuscular Administration

1997 • 54 citations

Serum interferon β-1a (Avonex) levels following intramuscular injection in relapsing-remitting MS patients

1998 • 39 citations

Inter-rater variability in reporting enhancing lesions present on standard and triple dose gadolinium scans of patients with multiple sclerosis

1997 • 17 citations

Treatment of Multiple Sclerosis with the Interferon-??s

1998 • 8 citations